Innovation strategies in medicines and vaccines within the scope of Ceis - models, mechanisms, and expectations
Bibliographic Data
| ID | 5335311 |
|---|---|
| Authors | Daniela Rangel Affonso Fernandes (0000-0002-0969-2707, Fundação Oswaldo Cruz), Carlos Augusto Grabois Gadelha (0000-0002-9148-8819, Fundação Oswaldo Cruz), Jose Manuel Santos De Varge Maldonado (0000-0002-0815-1765, Fundação Oswaldo Cruz) |
| Year | 2023 |
| Volume | 47 |
| Issue | 138 |
| Pages | 377-392 |
| Publication date | 2023-09-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Saúde em Debate (JOURNAL) |
| Journal identifiers | ISSN: 0103-1104 • E-ISSN: 2358-2898 |
| Publisher | FapUNIFESP (SciELO) (PUBLISHER) |
| DOI | 10.1590/0103-1104202313801i |
| OpenAlex | W4386832463 |
| SciELO | S0103-11042023000300377 |
| Language | EN |
| Citations received | 1 |
| References cited | 13 |
The article aimed to present relevant and original information about the innovation strategies used by Official Pharmaceutical Laboratories (LFO) to reduce the vulnerabilities of the Brazilian Unified Health System (SUS) and the productive and technological capacity of the Health Economic-Industrial Complex. The methods used included a literature review and the analysis of primary data from interviews conducted in two of the largest LFOs in the country. Their efforts and results in Research and Development (R&D) and incorporation of medicines and vaccine technologies were identified and analyzed, with emphasis on Productive Development Partnerships (PDP). Although R&D activities still need to advance, benefits were brought about by technology transfer agreements, especially by PDPs. However, the industrial and technological capacity of the Institutes is still limited and lacks investments, which hinders technological accumulation and diffusion. Thus, improvements are necessary so that the innovation strategies for the SUS present more effective results and can be reversed to the welfare of society
Business · Economics · Industrial organization · International trade · Public economics · Scope (computer science) · Technology transfer · Welfare · Biotechnology and Related Fields · Computer Science · Pharmaceutical Economics and Policy · Public Health in Brazil
Technical change and economic theory
O complexo econômico-industrial da saúde e a dimensão social e econômica do desenvolvimento
Competências científico- tecnológicas e cooperação universidade-empresa na saúde
Desenvolvimento, complexo industrial da saúde e política industrial
O papel dos produtores públicos de medicamentos e ações estratégicas na pandemia da Covid-19
Vulnerabilidades das indústrias nacionais de medicamentos e produtos biotecnológicos no contexto da pandemia de Covid-19
Avaliação da economicidade e da vantajosidade nas Parcerias para o Desenvolvimento Produtivo
| Citations per year | 1 |
|---|---|
| Citation span | 2026 - 2026 (1) |
| Highly cited | No |